A personal EKG monitor, an app that wirelessly connects to a smart thermometer, and 3 more FDA-cleared apps for primary care.
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction
ESC 2024: Findings from the FINEARTS-HF clinical trial provide the first definite evidence that an MRA can be beneficial in patients with HFmrEF/HFpEF.
Obesity & Pain Management: A Primary Viewpoints Podcast
In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.
Pfizer Has Launched PfizerForAll, an Online Multipronged Direct-to-Consumer Service
PfizerForAll offers telehealth and prescription services, vaccination scheduling and savings programs, and is partnering with recognized companies such as InstaCart.
FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes
The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.